Cerner finds a treasure in data mining - San Antonio Business Journal:

grearqakususi1426.blogspot.com
The North Kansas City-based health care information technologyt company, known mostly for the health-record softwarde sold to hospitals and is leveraging the billions of anonymous patienyt records it has at its disposal as marketablse information to pharmaceutical companies and Cerner said the data operation is a big reasohn revenue for its LifeSciencese Group has increased by roughly 20 percent durinyg each of the past five Mark Hoffman, the company’s life scienceas solutions vice president, predicted that annuao growth will be greater still in the future. “This is just the beginningh for us in thelife sciences,” he Included in Cerner’s data warehouss are 1.
2 billion lab results. It also has smaller numberss of medication orders andother data. The companyt collects the informationthrough data-sharing agreements with roughly 125 of its softwaree clients. By some estimates, it can take as long as 17 yearsdand $1.2 billion to develop a single drug. Cerner’s data-mining capabilities can quickenn that process and save money for drug companies by helpinvg the companies establish a stud protocol that maximizes the number of eligible candidatez fora trial. “We believ that can actually eventually reduce the cost of drug Hoffman said. Cerner woulrd not name its pharmaceutical customers.
Pharmaceutical companies and clinical researchers pay for Cernetr data forother reasons, said Scot Weir, director of the ’s Officde of Therapeutics Discovery and Development. He said Cerner’x data-mining capability can point scientists to potential new uses forexistinyg drugs. For instance, Weir said, Cerner’s databasse might suggest that a drug used to treatg cardiovascular disease could be helpful in treatinbcancer patients. Researchers then could run a clinical trialk to testthe idea.
The data is useful to drug companies for much the same Weir said, including helping them identifyy and correct side effects from The KU Cancer Center has used Cerner’s data-miningg capabilities for several “They uncover information we would never discover,” Weir said. “It’s He said Cerner stands to benefit as well, from collaborations with researchers that can lead to intellectuao property that produces licensintg fees and royalties. Cerner also can work with researchers suchas Dr. Stephenb Spielberg, director of the Center for Personalizerd Medicine and Therapeutic Innovationat . Spielberg seeksw a $3.
9 million grant from the for a study of how the centere can better capture data in pediatrivc cancer studies usingCerner